J1307 Injection, crovalimab-akkz, 10 milligrams
Also known as: Fabhalta II, crovalimab
Crovalimab-akkz injection supplied in 10 milligram units, a complement component 5 inhibitor for paroxysmal nocturnal hemoglobinuria.
In Plain Language
Subcutaneous blood disease medicine
Clinical Context
Used for treatment of paroxysmal nocturnal hemoglobinuria with subcutaneous administration and sustained complement C5 inhibition.
RVU Information
CPT J1307 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J1307?
CPT J1307 (Injection, crovalimab-akkz, 10 milligrams) is a J Codes (Drugs) code. Crovalimab-akkz injection supplied in 10 milligram units, a complement component 5 inhibitor for paroxysmal nocturnal hemoglobinuria.
How is J1307 administered?
CPT J1307 is administered by a healthcare provider, typically via injection or infusion. Used for treatment of paroxysmal nocturnal hemoglobinuria with subcutaneous administration and sustained complement C5 inhibition. It is used by Hematology, Internal Medicine, Transfusion Medicine.
When is CPT J1307 used?
Used for treatment of paroxysmal nocturnal hemoglobinuria with subcutaneous administration and sustained complement C5 inhibition.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.